1. ScholarBank@NUS

Muthu Kumaraswamy Shanmugam

rp02972

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Muthu Kumaraswamy Shanmugam
Variants
Shanmugam M.K.
 
Main Affiliation
 
Faculty
 
Email
muthu@nus.edu.sg
 
Researcher ID
 

Publications

Results 21-33 of 33 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
211-Sep-2021Resveratrol for cancer therapy: Challenges and future perspectivesRen, Boxu; Kwah, Marabeth Xin-Yi; Liu, Cuiliu; Ma, Zhaowu; Shanmugam, Muthu K. ; Ding, Lingwen ; Xiang, Xiaoqiang; Ho, Paul Chi-Lui ; Wang, Lingzhi ; Ong, Pei Shi ; Goh, Boon Cher 
222019Role of natural products in modulating histone deacetylases in cancerMerarchi, M.; Sethi, G. ; Shanmugam, M.K. ; Fan, L. ; Arfuso, F.; Ahn, K.S.
232018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M
42018Role of RNF20 in cancer development and progression – a comprehensive reviewSethi, G ; Shanmugam, M.K ; Arfuso, F; Kumar, A.P 
52020Sphingosine 1-phosphate receptor 2 induces otoprotective responses to cisplatin treatmentWang, W. ; Shanmugam, M.K. ; Xiang, P. ; Yam, T.Y.A. ; Kumar, V. ; Chew, W.S. ; Chang, J.K.; Ali, M.Z.B. ; Reolo, M.J.Y. ; Peh, Y.X. ; Karim, S.N.B.A. ; Tan, A.Y.Y. ; Sanda, T. ; Sethi, G. ; Herr, D.R. 
62017SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinomaSethi, G ; Shanmugam, M.K ; Kumar, A.P 
715-Apr-2019Targeting autophagy using natural compounds for cancer prevention and therapyDeng, Shuo ; Shanmugam, Muthu K ; Kumar, Alan Prem ; Yap, Celestial T ; Sethi, Gautam ; Bishayee, Anupam
82018The application of embelin for cancer prevention and therapyKo, J.-H; Lee, S.-G; Yang, W.M; Um, J.-Y; Sethi, G ; Mishra, S ; Shanmugam, M.K ; Ahn, K.S
92019The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and ChallengesLoh, C.-Y.; Chai, J.Y.; Tang, T.F.; Wong, W.F.; Sethi, G. ; Shanmugam, M.K. ; Chong, P.P.; Looi, C.Y.
102017The role of resveratrol in cancer therapyKo, J.-H; Sethi, G ; Um, J.-Y; Shanmugam, M.K ; Arfuso, F; Kumar, A.P ; Bishayee, A; Ahn, K.S
114-Dec-2018Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling AxisShanmugam, Muthu K ; Ahn, Kwang Seok; Hsu, Annie ; Woo, Chern Chiuh; Yuan, Yi; Tan, Kwong Huat Benny ; Chinnathambi, Arunachalam; Alahmadi, Tahani Awad; Alharbi, Sulaiman Ali; Koh, Angele Pei Fern; Arfuso, Frank; Huang, Ruby Yun-Ju; Lim, Lina HK ; Alan, Gautam Sethi ; Kumar, Alan Prem 
122014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G. 
132016Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathwayMohan C.D.; Srinivasa V.; Rangappa S.; Mervin L.; Mohan S.; Paricharak S.; Baday S.; Li F. ; Shanmugam M.K. ; Chinnathambi A.; Zayed M.E.; Alharbi S.A.; Bender A.; Sethi G. ; Basappa; Rangappa K.S.